Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126682641 | 12668264 | 1 | I | 20160801 | 20160819 | 20160819 | EXP | FR-WARNER CHILCOTT, LLC-1056537 | WARNER CHILCOTT | FRENCH HEALTH AUTHORITY (AN20160789/ FRA010820160191501) VIA TEVA PHARMACEUTICALS (682631ISR) | 79.00 | YR | F | Y | 0.00000 | 20160819 | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126682641 | 12668264 | 1 | PS | ACTONEL | RISEDRONATE SODIUM | 1 | Oral | Y | 20835 | 75 | MG | ||||||||
| 126682641 | 12668264 | 2 | C | LATANOPROST. | LATANOPROST | 1 | 0 | ||||||||||||
| 126682641 | 12668264 | 3 | C | Vivamyne (Vitamins NOS) | 2 | 0 | |||||||||||||
| 126682641 | 12668264 | 4 | C | DOLIPRANE | ACETAMINOPHEN | 1 | 0 | 500 | MG | ||||||||||
| 126682641 | 12668264 | 5 | C | FLECAINIDE ACETATE. | FLECAINIDE ACETATE | 1 | 0 | 150 | MG | ||||||||||
| 126682641 | 12668264 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | 20 | MG | ||||||||||
| 126682641 | 12668264 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | 15 | MG | ||||||||||
| 126682641 | 12668264 | 8 | C | MELOXICAM. | MELOXICAM | 1 | 0 | 15 | MG | ||||||||||
| 126682641 | 12668264 | 9 | C | Uvedose (Colecalciferol) | 2 | 0 | 100000 | IU | |||||||||||
| 126682641 | 12668264 | 10 | C | Macrogol (Macrogol) | 2 | 0 | |||||||||||||
| 126682641 | 12668264 | 11 | C | Klean Prep (Macrogol 3350, KCL, NA-bicarb, NaCl, Sodium Sulfate Anhyro | 2 | 0 | |||||||||||||
| 126682641 | 12668264 | 12 | C | Zymad (Colecalciferol) | 2 | 0 | 80000 | IU |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126682641 | 12668264 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126682641 | 12668264 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126682641 | 12668264 | Arthralgia | |
| 126682641 | 12668264 | Chills | |
| 126682641 | 12668264 | Cough | |
| 126682641 | 12668264 | Dysphagia | |
| 126682641 | 12668264 | Headache | |
| 126682641 | 12668264 | Hyperhidrosis | |
| 126682641 | 12668264 | Nausea | |
| 126682641 | 12668264 | Palpitations | |
| 126682641 | 12668264 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126682641 | 12668264 | 1 | 20160704 | 20160704 | 0 | |
| 126682641 | 12668264 | 12 | 20160602 | 0 |